Visonac: Phase IIb data

A double-blind, U.S. Phase IIb trial in 153 patients aged 12-35 with severe acne vulgaris showed that 4 treatments of topical

Read the full 211 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE